News
Additionally, Praluent was associated with a 15% lower risk of death from any cause, which occurred in 334 (3.5%) of patients in the Praluent group and 392 (4.1%) of patients in the placebo group.
Compared with a statin alone, the addition of Praluent cost $308 000 per quality-adjusted life year (QALY) gained. But the addition of ezetimibe cost $81 000 per QALY compared with a statin alone.
PARIS, March 18 (Reuters) - French far-right leader Marine Le Pen, who in two weeks will learn her fate in an embezzlement trial, says prosecutors demanding she face an instant five-year public ...
Following recent approvals in the EU, China and the U.S., this approval was based on pivotal Phase 3 results in adults with elevated eosinophils Approval marks the first new treatment approach for ...
The 2025 Comet EV comes with the MG e-Shield program, offering a vehicle warranty of 3 years or up to 1 lakh km, along with 3 years of roadside assistance and three complimentary labour services ...
Dupixent is available in Japan in a 300 mg dose as a pre-filled syringe or pre-filled pen and is now available for COPD. Dupixent is intended for injection under the skin (subcutaneous injection) and ...
Later in the afternoon, the excise team arrested two individuals with 250g of ganja and 300mg of MDMA during a raid held at Punnopady area. The arrested people were identified as Shalim from ...
When it debuted in 2005, the Chrysler 300 took North America by storm, quickly cementing itself as a pop culture icon. The flashy sedan was immediately popular with rappers like Snoop Dogg and 50 ...
About Dupixent Dupixent is available in Japan in a 300 mg dose as a pre-filled syringe or pre-filled pen and is now available for COPD. Dupixent is intended for injection under the skin ...
MG has played an important role at the entry-level end of Australia's new car market. Compact cars like the MG ZS SUV and MG 3 city car were often lauded for their affordable price and value-for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results